Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.
about
Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancerDNA methylation in adult diffuse gliomas.SFRP2 enhanced the adipogenic and neuronal differentiation potentials of stem cells from apical papilla.Effects and mechanism of GA-13315 on the proliferation and apoptosis of KB cells in oral cancer.Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.SIVcpz closely related to the ancestral HIV-1 is less or non-pathogenic to humans in a hu-BLT mouse model.
P2860
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Wnt pathway antagonists, SFRP1 ...... ion predicts shorter survival.
@en
type
label
Wnt pathway antagonists, SFRP1 ...... ion predicts shorter survival.
@en
prefLabel
Wnt pathway antagonists, SFRP1 ...... ion predicts shorter survival.
@en
P2093
P2860
P1476
Wnt pathway antagonists, SFRP1 ...... tion predicts shorter survival
@en
P2093
Aleksandra Majchrzak-Celińska
Anna-Maria Barciszewska
Marta Słocińska
Stanisław Nowak
P2860
P2888
P304
P356
10.1007/S13353-015-0312-7
P577
2015-09-04T00:00:00Z